BACKGROUND: Human papillomavirus (HPV) vaccines have been shown to be safe and highly effective in young and middle-aged women. PURPOSE: This study aimed to assess vaccine awareness and desire for vaccination among adult women aged 18-55 years residing in Los Angeles County CA. METHODS: This study is nested in the 2007 Los Angeles County Health Survey. Included in the analyses were 2295 women aged 18-55 years. Logistic regression was used to evaluate vaccine awareness and intention to become vaccinated in association with various factors. All analyses employed weighted data and were conducted in 2009. RESULTS: Only 5% of women aged 18-26 years had received the HPV vaccine in its first year on the market. Overall, 67% of women aged 18-55 years had heard of the vaccine. Among those who knew of the vaccine but had not received it, 61% reported they were likely to receive the vaccine. Latina, black, and Asian/Pacific Islander women were only half as likely to have heard of the vaccine as white women, but Latinas and Asian/Pacific Islander women were more willing to be vaccinated than white or black women. Education was associated positively with awareness, but inversely associated with intention to be vaccinated. Awareness and desire for vaccination also varied substantially by other factors such as language spoken at home. CONCLUSIONS: This population-based study of diverse women reveals important disparities in HPV vaccine awareness and intention to be vaccinated. Culturally and linguistically competent educational campaigns about HPV immunization are warranted, and should target high-risk populations.
BACKGROUND:Human papillomavirus (HPV) vaccines have been shown to be safe and highly effective in young and middle-aged women. PURPOSE: This study aimed to assess vaccine awareness and desire for vaccination among adult women aged 18-55 years residing in Los Angeles County CA. METHODS: This study is nested in the 2007 Los Angeles County Health Survey. Included in the analyses were 2295 women aged 18-55 years. Logistic regression was used to evaluate vaccine awareness and intention to become vaccinated in association with various factors. All analyses employed weighted data and were conducted in 2009. RESULTS: Only 5% of women aged 18-26 years had received the HPV vaccine in its first year on the market. Overall, 67% of women aged 18-55 years had heard of the vaccine. Among those who knew of the vaccine but had not received it, 61% reported they were likely to receive the vaccine. Latina, black, and Asian/Pacific Islander women were only half as likely to have heard of the vaccine as white women, but Latinas and Asian/Pacific Islander women were more willing to be vaccinated than white or black women. Education was associated positively with awareness, but inversely associated with intention to be vaccinated. Awareness and desire for vaccination also varied substantially by other factors such as language spoken at home. CONCLUSIONS: This population-based study of diverse women reveals important disparities in HPV vaccine awareness and intention to be vaccinated. Culturally and linguistically competent educational campaigns about HPV immunization are warranted, and should target high-risk populations.
Authors: Peng-Jun Lu; Walter W Williams; Jun Li; Christina Dorell; David Yankey; Deanna Kepka; Eileen F Dunne Journal: Am J Prev Med Date: 2013-04 Impact factor: 5.043
Authors: F Xavier Bosch; Claudia Robles; Mireia Díaz; Marc Arbyn; Iacopo Baussano; Christine Clavel; Guglielmo Ronco; Joakim Dillner; Matti Lehtinen; Karl-Ulrich Petry; Mario Poljak; Susanne K Kjaer; Chris J L M Meijer; Suzanne M Garland; Jorge Salmerón; Xavier Castellsagué; Laia Bruni; Silvia de Sanjosé; Jack Cuzick Journal: Nat Rev Clin Oncol Date: 2015-09-01 Impact factor: 66.675
Authors: Kevin A Henry; Antoinette M Stroup; Echo L Warner; Deanna Kepka Journal: Cancer Epidemiol Biomarkers Prev Date: 2016-01-14 Impact factor: 4.254